about
Imbalances in serum angiopoietin concentrations are early predictors of septic shock development in patients with post chemotherapy febrile neutropeniaNitric oxide regulates human eosinophil adhesion mechanisms in vitro by changing integrin expression and activity on the eosinophil cell surfaceThe prognostic value of maturation-associated phenotypic abnormalities in myelodysplastic syndromes.[Morphology of bone marrow in systemic lupus erythematosus]A high angiopoietin-2/angiopoietin-1 ratio is associated with a high risk of septic shock in patients with febrile neutropeniaThe impact of maternal HIV infection on cord blood lymphocyte subsets and cytokine profile in exposed non-infected newborns.Vanishing bile duct syndrome in Hodgkin's disease: case report.Fractal characteristics of May-Grünwald-Giemsa stained chromatin are independent prognostic factors for survival in multiple myeloma.No contribution of GSTM1 and GSTT1 null genotypes to the risk of neutropenia due to benzene exposure in Southeastern BrazilTime-course of sFlt-1 and VEGF-A release in neutropenic patients with sepsis and septic shock: a prospective studyScreening for hotspot mutations in PI3K, JAK2, FLT3 and NPM1 in patients with myelodysplastic syndromes.Immunophenotyping in myelodysplastic syndromes can add prognostic information to well-established and new clinical scores.Computerized texture analysis of atypical immature myeloid precursors in patients with myelodysplastic syndromes: an entity between blasts and promyelocytes.Improving the differential diagnosis between myelodysplastic syndromes and reactive peripheral cytopenias by multiparametric flow cytometry: the role of B-cell precursors.Low educational level but not low income impairs the achievement of cytogenetic remission in chronic myeloid leukemia patients treated with imatinib in Brazil.Treatment with dasatinib or nilotinib in chronic myeloid leukemia patients who failed to respond to two previously administered tyrosine kinase inhibitors--a single center experienceBrazilian experience using high dose sequential chemotherapy followed by autologous hematopoietic stem cell transplantation for malignant lymphomas.Stathmin 1 inhibition amplifies ruxolitinib-induced apoptosis in JAK2V617F cellsLow Ten-eleven-translocation 2 (TET2) transcript level is independent of TET2 mutation in patients with myeloid neoplasms.Primary myelofibrosis: risk stratification by IPSS identifies patients with poor clinical outcome.IRS2 silencing increases apoptosis and potentiates the effects of ruxolitinib in JAK2V617F-positive myeloproliferative neoplasms.Circulating progenitor and mature endothelial cells in deep vein thrombosisDiagnosis and treatment of chronic lymphocytic leukemia: recommendations from the Brazilian Group of Chronic Lymphocytic Leukemia.A Novel Assay for the Identification of NOTCH1 PEST Domain Mutations in Chronic Lymphocytic Leukemia.Leptin inhibits apoptosis in thymus through a janus kinase-2-independent, insulin receptor substrate-1/phosphatidylinositol-3 kinase-dependent pathway.Diagnosis of chronic lymphoproliferative disorders by flow cytometry using four-color combinations for immunophenotyping: A proposal of the Brazilian Group of Flow Cytometry (GBCFLUX).Characteristics of the phenotypic abnormalities of bone marrow cells in childhood myelodysplastic syndromes and juvenile myelomonocytic leukemia.Molecular identification of the HLA-DRB1-DQB1 for diagnosis and follow-up of acute leukemias.Influence of BCR-ABL Transcript Type on Outcome in Patients With Chronic-Phase Chronic Myeloid Leukemia Treated With Imatinib.Multiple lymphoid nodules in bone marrow biopsy in immunocompetent patient with cytomegalovirus infection: an immunohistochemical analysis.The Brazilian Pediatric Myelodysplastic Cooperative Group strategies: are they relevant to improve educational approach and correct diagnosis?The utility of multiparametric flow cytometry for the detection of minimal residual disease in acute lymphoblastic leukemia.Myelodysplastic syndrome with synchronous gastric cancer: when the symptoms suggest something else.Erratum to "Diagnosis and treatment of chronic lymphocytic leukemia: Recommendations from the Brazilian Group of Chronic Lymphocytic Leukemia" [Rev Bras Hematol Hemoter. 2016;38(4):346-357].Effect of cytokines and chemokines on sickle neutrophil adhesion to fibronectin.Somatic mutations of calreticulin in a Brazilian cohort of patients with myeloproliferative neoplasms.Age related decrease of AgNOR activity in acute and chronic lymphocytic leukaemias.Concomitant essential thrombocythemia with JAK2 V617F mutation in a patient with chronic myeloid leukemia with major molecular response with imatinib and long-term follow-up.Microparticles in deep venous thrombosis, antiphospholipid syndrome and Factor V Leiden.Brazilian experience using high-dose sequential chemotherapy followed by autologous hematopoietic stem cell transplantation for relapsed or refractory Hodgkin lymphoma.
P50
Q21261838-7C5414AC-E4B7-47E6-B470-9BBDB2117363Q28361083-885D7C92-D4FB-4DE4-9F95-E9E14E8F45C5Q33376131-C2393744-6391-4ECF-A490-D475A1603DE0Q33490205-E0BC4A18-9B9A-4472-8648-4A4FB22C8391Q33752686-77002DCF-611F-4F29-8E70-A24FBEDEBCDAQ33811277-CB69469B-756E-4828-8297-9267706EC8E6Q33920294-5E616DBB-F333-422C-96A9-CF1737029662Q33941055-6F3EC6AA-A016-4FFE-8A92-A6813EE44C83Q34565444-EF0F5748-03C3-4178-B27F-BA4D3EDD8AD0Q34677335-9FBFCD5D-6730-494D-81AC-ADEA183E340BQ35028968-8D1F9D52-E21B-4613-8CDC-9D480499A14AQ35063862-F885973A-61AD-419A-8ECC-BB5FC79D1800Q35373199-B7BA17B9-EFF3-4FCC-8ECB-22C95678A732Q35596082-F9C80DC9-B2C0-4E6E-8217-35A3D5A51EE7Q35666534-EBD72A05-C049-45CB-8E71-7C8EFA980823Q35899653-84B5E289-3917-4124-B575-B09BE48D69B9Q36283067-83139372-C7AE-49D7-9054-9DD47FAFA6D6Q36557368-7DA5B85A-7E7D-4198-B462-0E0398741F73Q36691624-00AA5D67-1CC8-4955-AC04-A05F2C1B5B93Q36727581-763810B6-349E-4FAB-A74B-5FFF05D120DFQ36916389-FCED5AA2-8961-46E6-98E8-6A61FC690B56Q37249340-06EAEFF6-75E7-45E7-B969-AEC6B85AEA1CQ37429218-38AED78B-7E1A-4BD3-BF20-0EE2E757F8C9Q37542431-4DD3EC14-BB9C-4527-A330-9250F9011280Q38311116-992AE02E-31BE-430E-B62F-2E9F33B14675Q38881884-48447269-F278-437E-B3A0-64E0190733EBQ39284013-917193F3-8541-445B-A4C1-25053A7C22EFQ39912411-0956D796-AA0E-46F5-80DF-2D76E4731833Q40077637-5B28EFC2-AF8C-4894-A82A-793B505A572BQ40596425-78F20D9E-D993-4BAA-951A-693673CCAE8EQ40640715-E761225B-0644-4A98-BC75-7FE9EF0806E7Q41561336-20E38CB0-785C-41E1-8B7B-F8AA6FB19929Q41631253-5AC185E8-C7C0-49C1-B87D-8286F40279D4Q42318020-B4C3CC44-3694-4403-98BD-0C2DB63498F7Q42476322-9856130B-D703-43CA-96FD-2E4E84BC8341Q42585822-8D8A6386-E09E-412B-A7B7-1F3DA338DAF5Q42610312-EE054B11-7CDA-40CB-930E-C4EFF83281E6Q42709330-A13D8A4C-5FD7-47CD-A3FB-5766D3857066Q43265582-3910380B-B490-438C-BD29-E7490DAEC457Q44101527-3830ADDD-BCD9-4B6B-805F-B5202FC14AB5
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
wetenschapper
@nl
研究者
@zh
name
I Lorand-Metze
@ast
I Lorand-Metze
@en
I Lorand-Metze
@es
I Lorand-Metze
@nl
type
label
I Lorand-Metze
@ast
I Lorand-Metze
@en
I Lorand-Metze
@es
I Lorand-Metze
@nl
prefLabel
I Lorand-Metze
@ast
I Lorand-Metze
@en
I Lorand-Metze
@es
I Lorand-Metze
@nl
P31
P496
0000-0002-6516-1265